Throughout this section of the package insert, the Aranesp™ study numbers In 2 open-label studies, Aranesp™ or Epoetin alfa were administered for the. Package Insert Aranesp (Darbepoetin alfa) Amgen Inc. Table of Contents. Description Clinical Pharmacology Clinical Studies Indications and. This patient package insert contains information and directions for patients who will be receiving injections of Aranespä and their caregivers.

Author: Samuran Kajisho
Country: Botswana
Language: English (Spanish)
Genre: Science
Published (Last): 10 September 2004
Pages: 326
PDF File Size: 6.44 Mb
ePub File Size: 4.76 Mb
ISBN: 312-8-88792-208-2
Downloads: 84033
Price: Free* [*Free Regsitration Required]
Uploader: Tugal

Anemia of chronic kidney disease CKDincluding patients on and not on dialysis.

Report on New Patented Drugs – Aranesp

Do not give Aranesp to a child. Some of the side effects listed below may be due to your kidney failure rather than Aranesp. Discontinue after completion of chemotherapy course. If someone else is injecting for you, they can also use the back of your arms. Further, the accuracy, currency and completeness of the atanesp available on this Web site cannot be guaranteed.

ARANESP Dosage & Rx Info | Uses, Side Effects – MPR

Aeanesp this condition develops, patients lose the good response they have been having to the treatment for anaemia. Wash your hands thoroughly with soap and water.

An overview of the efficacy inserrt safety of novel erythropoiesis stimulating protein NESP. Before you use it When you must not use Aranesp Before you start to use it Taking other medicines. If there are any problems with administering the product, place the product back into original packaging and contact a pharmacy.


Your Aranesp has now been fully injected. Dietary clues to a healthy microbiome.

Erythropoietin encourages your bone marrow to produce more red blood cells. Generic Name and Formulations: PUSH the plunger with slow and constant pressure until you feel or hear a “snap”. Your doctor will decide which injection frequency is best for you. Eprex also shares the same indication as Aranesp and is used in Canada for treating anaemia in patients with chronic renal failure.

You can give yourself a subcutaneous injection after you have received training from your doctor or nurse.

Chemotherapy-induced anemia in patients with non-myeloid aranwsp. Your doctor will work out the correct amount of Aranesp for you and tell you how much you must take.

We’re strengthening digital security to protect you.

This will be possible without excessive pressure. Dispose of the full puncture-resistant sharps container as instructed by your doctor, nurse or pharmacist.

Catch up on the weekend. Where to inject How to inject. Place the pre-filled pen on the injection site at a right packge 90 degrees and push firmly against the skin. They may differ from the information in this leaflet.

Open the tray, peeling away the cover. Evaluate serum iron, ferritin, transferrin saturation before and during therapy; most patients will need iron supplementation.


Digital Security

Your doctor has prescribed the strength of Aranesp that is best for you. New cancer test is as good as gold. Aranesp is a recombinant erythropoietic protein produced by special mammalian cells. Talk to your doctor, nurse or pharmacist if you have any questions about this information.

Increased risk of tumor progression or recurrence in cancer patients. Novel erythropoiesis stimulating protein NESP safely maintains hemoglobin concentration levels in hemodialysis patients as effectively as r-HuEPO when administered once weekly.

These measures will help to protect the environment. Date of First Sale: Indication as per For the treatment of anaemia associated with chronic renal failure product monograph: Monitor BP reduce or withhold dose if hypertension occursfolate, Vit. After releasing the plunger, the pre-filled syringe safety guard will safely cover the injection needle.

It will reduce your need for blood transfusions. DO NOT put the grey needle cover back on the used pre-filled syringe. August 2, Date of First Sale: Do not use in patients with pure red cell aplasia due to erythropoietin antibodies.